11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Source Url: https://www.jdsupra.com/legalnews/covid-19-report-for-life-sciences-and-24214/
Related
Construction “of all kind” has been listed as a Critical Sector and exempt under the recent Stay a...
Read More >
Governor Newsom pledges extra $200 million for homeless housing - Bullet The Mercury News – Octob...
Read More >
The Department of Labor (DOL) adopted a final rule on January 12, 2020, to revise and update its Par...
Read More >
Seyfarth Synopsis: The Tenth Circuit Court of Appeals recently affirmed summary judgment in favor of...
Read More >
It's easier to lose your job if your replacement is a robot. In an interesting bit of industrial ps...
Read More >
Reserve Quotas for Disabled Employees and Mass Dismissals - Precedential Decision by Judiciary or R...
Read More >